Erythropoietin Is a Paracrine Mediator of Ischemic Tolerance in the Brain: Evidence from an<i>In Vitro</i>Model
Karsten Ruscher(Institute of Experimental Endocrinology of the Slovak Academy of Sciences), Andreas Meisel(Charité - Universitätsmedizin Berlin)
Cited by 387
Related Papers
Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model.
|PubMed|2002|452
Blocking Stroke-Induced Immunodeficiency Increases CNS Antigen-Specific Autoreactivity But Does Not Worsen Functional Outcome after Experimental Stroke
|Journal of Neuroscience|2015|76
Mental health in myasthenia gravis patients and its impact on caregiver burden
|Scientific Reports|2022|36
Plasticity-Enhancing Effects of Levodopa Treatment after Stroke
|International Journal of Molecular Sciences|2021|12